EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Artificial Intelligence in Colorectal Cancer Histopathology: From Image Analysis to Clinical Translation—A Systematic Review

Andreas Antzoulas, Francesk Mulita, Vasileios Leivaditis, Elias Liolis, Konstantinos Tasios, Georgios-Ioannis Verras, Dimitrios Litsas, George Theofanis, Konstantinos Bouchagier, Ioannis Maroulis

Cancers · 15.11.2026 · 18 (22) · 3656

DOI: 10.3390/cancers18223656 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancers, online erschienen am 15.11.2026. Verfasst von Andreas Antzoulas und 9 weiteren Autor:innen. Die Arbeit nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Convolutional neural networks (CNNs) are increasingly applied to haematoxylin and eosin (H&E)-stained colorectal cancer (CRC) histopathology, but it remains unclear how far reported performance reflects readiness for clinical use.

Methods

Following PRISMA 2020, PubMed and Scopus were searched to 30 August 2026, and two reviewers independently selected studies; 102 studies were included. Each was classified by principal task, level of analysis, and validation strategy, and risk of bias was assessed with an adapted QUADAS-2 tool.

Results

Most studies addressed binary tumour-versus-benign classification (53.9%) or multiclass tissue classification (26.5%); dysplasia grading, segmentation, and molecular prediction were less common. Over half evaluated isolated patches, 62.7% relied on public datasets, and only 21.6% tested a fixed model on an independent external cohort. Only 6 (5.9%) studies were at low risk of bias. Near-perfect accuracies came mainly from randomly partitioned benchmarks, performance declined on independent cohorts, and no study reported a prospective trial.

Conclusions

This systematic review provides a task- and validation-stratified appraisal of CNNs in CRC histopathology, showing that the main barrier to clinical adoption is no longer algorithmic accuracy but the quality of validation evidence. Patient-level data separation, multicentre external validation, slide-level evaluation, and prospective evaluation of pathologist–AI collaboration are priorities.

Zitieren

APA

Antzoulas, A., Mulita, F., Leivaditis, V., Liolis, E., Tasios, K., Verras, G., Litsas, D., Theofanis, G., Bouchagier, K., & Maroulis, I. (2026). Artificial Intelligence in Colorectal Cancer Histopathology: From Image Analysis to Clinical Translation—A Systematic Review. Cancers, 18(22), 3656. https://doi.org/10.3390/cancers18223656

Vancouver

Antzoulas A, Mulita F, Leivaditis V, Liolis E, Tasios K, Verras G, et al. Artificial Intelligence in Colorectal Cancer Histopathology: From Image Analysis to Clinical Translation—A Systematic Review. Cancers. 2026;18(22):3656. doi:10.3390/cancers18223656

BibTeX
@article{Antzoulas2026,
  author = {Antzoulas, Andreas and Mulita, Francesk and Leivaditis, Vasileios and Liolis, Elias and Tasios, Konstantinos and Verras, Georgios-Ioannis and Litsas, Dimitrios and Theofanis, George and Bouchagier, Konstantinos and Maroulis, Ioannis},
  title = {Artificial Intelligence in Colorectal Cancer Histopathology: From Image Analysis to Clinical Translation—A Systematic Review},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {22},
  pages = {3656},
  doi = {10.3390/cancers18223656}
}
Kostenlos starten →